Leading Financial Service Provider in India | Canara Bank Securities Ltd

Dipna Pharmachem Ltd.

Aug 22 BSE 19.95 (+ 0.42 2.15%)

Volume120000

Prev. Close
19.53

Open Price
19.69

Today's Low / High

19.00 20.19

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

6.40 26.31

Dipna Pharmachem Ltd.is not traded in NSE

Market Cap. ( ₹ in Cr. )	47.97	P/BV	1.28	Book Value ( ₹ )	15.60
52 Week High/Low ( ₹ )	26/6	FV/ML	10/3000	P/E(X)	49.26
Book Closure	27/08/2024	EPS ( ₹ )	0.41	Div Yield (%)	0.00

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	124.92	164.34	99.93	72.76	31.00
Total Operating Revenues	124.92	164.34	99.93	72.76	31.00

Other Income	0.01	0.00	0.01	0.01	0.02
Total Revenue	124.93	164.34	99.93	72.77	31.02

EXPENSES
Cost Of Materials Consumed	0.00	0.00	0.00	67.67	31.22
Purchase Of Stock-In Trade	103.78	176.35	108.13	0.00	0.00
Operating And Direct Expenses	0.00	0.00	0.00	0.05	0.01
Changes In Inventories Of FG,WIP And Stock-In Trade	9.95	-18.44	-12.64	0.89	-1.64
Employee Benefit Expenses	0.41	0.44	0.44	0.61	0.41
Finance Costs	2.02	2.00	0.96	0.67	0.35
Depreciation And Amortisation Expenses	0.01	0.02	0.01	0.01	0.01
Other Expenses	7.34	2.56	1.66	1.29	0.60
Total Expenses	123.51	162.92	98.55	71.19	30.96

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1.42	1.42	1.38	1.57	0.06

Profit/Loss Before Tax	1.42	1.42	1.38	1.57	0.06

Tax Expenses-Continued Operations
Current Tax	0.45	0.34	0.47	0.41	0.03
Total Tax Expenses	0.45	0.33	0.47	0.41	0.03
Profit/Loss After Tax And Before ExtraOrdinary Items	0.97	1.09	0.91	1.17	0.02

Profit/Loss From Continuing Operations	0.97	1.09	0.91	1.17	0.02

Profit/Loss For The Period	0.97	1.09	0.91	1.17	0.02

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	0.41	0.45	260.55	333.40	6.91
Diluted EPS (Rs.)	0.41	0.45	260.55	333.40	6.91

Markets

Income Statement

INCOME STATEMENT

Dipna Pharmachem Ltd.